Clinical Trial Update: Diabetic Retinopathy Study (DRS) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial for diabetic retinopathy sponsored by the National Eye Institute has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blindness
• Diabetic Retinopathy

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Diabetic Retinopathy, Blindness | Phase 3 | Status: COMPLETED